rdf:type |
|
lifeskim:mentions |
umls-concept:C0013126,
umls-concept:C0017262,
umls-concept:C0026882,
umls-concept:C0037993,
umls-concept:C0086222,
umls-concept:C0185117,
umls-concept:C0205263,
umls-concept:C0229601,
umls-concept:C0231174,
umls-concept:C1333663,
umls-concept:C1523987,
umls-concept:C1705733,
umls-concept:C2674219,
umls-concept:C2911684
|
pubmed:issue |
10
|
pubmed:dateCreated |
2009-9-4
|
pubmed:abstractText |
Rigorously defined reconstitution assays developed in recent years have allowed recognition of the delicate relationship that exists between hematopoietic stem cells and their niches. This balance ensures that hematopoiesis occurs in the marrow under steady-state conditions. However, during development, recovery from hematopoietic stress and in myeloproliferative disorders, hematopoiesis occurs in extramedullary sites whose microenvironments are still poorly defined. The hypomorphic Gata1(low) mutation deletes the regulatory sequences of the gene necessary for its expression in hematopoietic cells generated in the marrow. By analyzing the mechanism that rescues hematopoiesis in mice carrying this mutation, we provide evidence that extramedullary microenvironments sustain maturation of stem cells that would be otherwise incapable of maturing in the marrow.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1528-0020
|
pubmed:author |
pubmed-author:Di BaldassarreAngelaA,
pubmed-author:FibbeWillem EWE,
pubmed-author:GhinassiBarbaraB,
pubmed-author:MartelliFabrizioF,
pubmed-author:MigliaccioAnna RitaAR,
pubmed-author:MigliaccioGiovanniG,
pubmed-author:RanaRosa AlbaRA,
pubmed-author:SanchezMassimoM,
pubmed-author:ValeriMauroM,
pubmed-author:VannucchiAlessandro MariaAM,
pubmed-author:VerrucciMariaM,
pubmed-author:ZingarielloMariaM,
pubmed-author:van HensbergenYvetteY
|
pubmed:issnType |
Electronic
|
pubmed:day |
3
|
pubmed:volume |
114
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2107-20
|
pubmed:dateRevised |
2010-9-6
|
pubmed:meshHeading |
pubmed-meshheading:19571316-Animals,
pubmed-meshheading:19571316-Bone Marrow,
pubmed-meshheading:19571316-Enhancer Elements, Genetic,
pubmed-meshheading:19571316-GATA1 Transcription Factor,
pubmed-meshheading:19571316-Gene Expression Regulation,
pubmed-meshheading:19571316-Hematopoiesis, Extramedullary,
pubmed-meshheading:19571316-Hematopoietic Stem Cells,
pubmed-meshheading:19571316-Mice,
pubmed-meshheading:19571316-Mice, Mutant Strains,
pubmed-meshheading:19571316-Mutation,
pubmed-meshheading:19571316-Myeloproliferative Disorders,
pubmed-meshheading:19571316-Stress, Physiological
|
pubmed:year |
2009
|
pubmed:articleTitle |
Gata1 expression driven by the alternative HS2 enhancer in the spleen rescues the hematopoietic failure induced by the hypomorphic Gata1low mutation.
|
pubmed:affiliation |
Department of Hematology/Oncology and Molecular Medicine, Instituto Superiore Sanità, Rome, Italy. annarita.migliaccio@mssm.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|